Skip To The Main Content

Can ICH Q12 Unlock Manufacturing Innovation?

June 2018

Human medicine has come a long way in the last 100 years. Paradigm-changing therapies have made their way into the clinic since the end of the last century, nurtured by better understanding of the underlying causes of various diseases. These 21st century cures entail personalized therapies using genomics, targeted tumor therapies using antibody–drug conjugates along with cell and gene therapies, just to name a few. These therapies are giving hope to millions of patients. In addition, they profoundly impact multiple stakeholders in the healthcare sector, including the pharmaceutical industry.

You need to Login to view the full article. Please Login. Not a Member? Join today!

PDA Members Save Substantially